Aptevo Therapeutics Incorporated (NASDAQ:APVO) Can’t Be Less Risky. Short Interest Decreased

October 13, 2017 - By Peter Erickson

 Aptevo Therapeutics Incorporated (NASDAQ:APVO) Can't Be Less Risky. Short Interest Decreased

The stock of Aptevo Therapeutics Incorporated (NASDAQ:APVO) registered a decrease of 16.72% in short interest. APVO’s total short interest was 318,200 shares in October as published by FINRA. Its down 16.72% from 382,100 shares, reported previously. With 92,900 shares average volume, it will take short sellers 3 days to cover their APVO’s short positions. The short interest to Aptevo Therapeutics Incorporated’s float is 2.12%.

The stock decreased 1.62% or $0.04 on October 13, reaching $2.43. About 233,948 shares traded. Aptevo Therapeutics Inc (NASDAQ:APVO) has 0.00% since October 13, 2016 and is . It has underperformed by 16.70% the S&P500.

Aptevo Therapeutics Inc. is a biotechnology company. The company has market cap of $52.05 million. The Firm is focused on oncology and hematology therapeutics. It currently has negative earnings. The Firm is engaged in the discovery, development, commercialization and sale of oncology and hematology therapeutics.

More recent Aptevo Therapeutics Inc (NASDAQ:APVO) news were published by: Seekingalpha.com which released: “Aptevo Therapeutics: Slowly Grinding Higher” on October 12, 2017. Also Seekingalpha.com published the news titled: “Aptevo Therapeutics Likely Worth At Least $5 A Share” on September 01, 2017. Globenewswire.com‘s news article titled: “Aptevo Therapeutics Extends Cash Runway $20 Million; Retains Term Loan …” with publication date: September 28, 2017 was also an interesting one.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.